Schedule 13G ownership disclosure
CYMABAY THERAPEUTICS INC
Security class unavailable · CUSIP: 23257D103
Event date: 2019-07-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001319244-19-000068
- Form type
- SC 13G
- Filer
- CymaBay Therapeutics, Inc.
- CIK
- CIK 1042074
- Filed
- Aug 01, 2019
- Reporting period
- Jul 23, 2019
- Description
- Schedule 13G beneficial ownership